Literature DB >> 31930551

Safety and efficacy of interferon γ in friedreich's ataxia.

Marinela Vavla1, Maria Grazia D'Angelo1, Filippo Arrigoni1, Nicola Toschi2,3, Denis Peruzzo1, Sandra Gandossini1, Annamaria Russo1, Eleonora Diella1, Stefania Tirelli1, Roberto Salati1, Paolo Scarpazza1, Riccardo Luffarelli2,4, Silvia Fortuni2, Alessandra Rufini2,4, Ivano Condò2, Roberto Testi2,4, Andrea Martinuzzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31930551     DOI： 10.1002/mds.27979

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  4 in total

Review 1.  Friedreich ataxia: clinical features and new developments.

Authors:  Medina Keita; Kellie McIntyre; Layne N Rodden; Kim Schadt; David R Lynch
Journal:  Neurodegener Dis Manag       Date:  2022-06-29

2.  Molecular Mechanism of the Regulatory Effect of Schisandrol A on the Immune Function of Mice Based on a Transcription Factor Regulatory Network.

Authors:  Guangyu Xu; Yanbo Feng; Han Li; Cong Chen; He Li; Chunmei Wang; Jianguang Chen; Jinghui Sun
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

Review 3.  Drug Repositioning in Friedreich Ataxia.

Authors:  Alessandra Rufini; Florence Malisan; Ivano Condò; Roberto Testi
Journal:  Front Neurosci       Date:  2022-02-09       Impact factor: 4.677

4.  Functional MRI Studies in Friedreich's Ataxia: A Systematic Review.

Authors:  Marinela Vavla; Filippo Arrigoni; Denis Peruzzo; Domenico Montanaro; Francesca Frijia; Silvia Pizzighello; Alberto De Luca; Emma Della Libera; Federica Tessarotto; Paola Guerra; Ian H Harding; Andrea Martinuzzi
Journal:  Front Neurol       Date:  2022-03-10       Impact factor: 4.003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.